Ikarian Capital, LLC Portfolio Holdings

Ikarian Capital, LLC

  • $640 Million
  • Q3 2025

Ikarian Capital, LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $640 Million distributed in 169 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ionis Pharmaceuticals Inc with a value of $27.2M, Ptc Therapeutics, Inc. with a value of $17.2M, Cytokinetics Inc with a value of $12.2M, Vaxcyte, Inc. with a value of $11.2M, and Fulcrum Therapeutics, Inc. with a value of $11.2M.

Examining the 13F form we can see an increase of $312M in the current position value, from $328M to 640M.

Ikarian Capital, LLC is based out at Dallas, TX

Below you can find more details about Ikarian Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $640 Million
Healthcare: $561 Million
ETFs: $75.2 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 169
  • Current Value $640 Million
  • Prior Value $328 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 38 stocks
  • Additional Purchases 22 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 29 stocks
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email